154 related articles for article (PubMed ID: 38200472)
1. Possible prognostic impact of PKCι genetic variants in prostate cancer.
Hafeez A; Shabbir M; Khan K; Trembley JH; Badshah Y; Zafar S; Shahid K; Shah H; Ashraf NM; Hamid A; Afsar T; Almajwal A; Marium A; Razak S
Cancer Cell Int; 2024 Jan; 24(1):24. PubMed ID: 38200472
[TBL] [Abstract][Full Text] [Related]
2. Targeting the oncogenic protein kinase Ciota signalling pathway for the treatment of cancer.
Fields AP; Frederick LA; Regala RP
Biochem Soc Trans; 2007 Nov; 35(Pt 5):996-1000. PubMed ID: 17956262
[TBL] [Abstract][Full Text] [Related]
3. Recurrent copy number gains drive PKCι expression and PKCι-dependent oncogenic signaling in human cancers.
Liu Y; Justilien V; Fields AP; Murray NR
Adv Biol Regul; 2020 Dec; 78():100754. PubMed ID: 32992230
[TBL] [Abstract][Full Text] [Related]
4. Two novel PRKCI polymorphisms and prostate cancer risk in an Eastern Chinese Han population.
Li Q; Gu C; Zhu Y; Wang M; Yang Y; Wang J; Jin L; Zhu ML; Shi TY; He J; Ye D; Wei Q
Mol Carcinog; 2015 Aug; 54(8):632-41. PubMed ID: 24510606
[TBL] [Abstract][Full Text] [Related]
5. Investigating pathogenic SNP of PKCι in HCV-induced hepatocellular carcinoma.
Khan N; Khan K; Badshah Y; Trembley JH; Ashraf NM; Shabbir M; Danish L; Afsar T; Almajwal A; Justin S; Hasan Z; Razak S
Sci Rep; 2023 Aug; 13(1):12504. PubMed ID: 37532886
[TBL] [Abstract][Full Text] [Related]
6. Aurothiomalate inhibits transformed growth by targeting the PB1 domain of protein kinase Ciota.
Erdogan E; Lamark T; Stallings-Mann M; Lee Jamieson ; Pellecchia M; Thompson EA; Johansen T; Fields AP
J Biol Chem; 2006 Sep; 281(38):28450-9. PubMed ID: 16861740
[TBL] [Abstract][Full Text] [Related]
7. Addiction to protein kinase Cɩ due to PRKCI gene amplification can be exploited for an aptamer-based targeted therapy in ovarian cancer.
Rehmani H; Li Y; Li T; Padia R; Calbay O; Jin L; Chen H; Huang S
Signal Transduct Target Ther; 2020 Aug; 5(1):140. PubMed ID: 32820156
[TBL] [Abstract][Full Text] [Related]
8. Association of polymorphisms in PRKCI gene and risk of prostate cancer in a sample of Iranian Population.
Hashemi M; Shahkar G; Simforoosh N; Basiri A; Ziaee SA; Narouie B; Taheri M
Cell Mol Biol (Noisy-le-grand); 2015 Oct; 61(5):16-21. PubMed ID: 26475383
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase Cι expression and oncogenic signaling mechanisms in cancer.
Murray NR; Kalari KR; Fields AP
J Cell Physiol; 2011 Apr; 226(4):879-87. PubMed ID: 20945390
[TBL] [Abstract][Full Text] [Related]
10. Coordination of glioblastoma cell motility by PKCι.
Baldwin RM; Barrett GM; Parolin DA; Gillies JK; Paget JA; Lavictoire SJ; Gray DA; Lorimer IA
Mol Cancer; 2010 Sep; 9():233. PubMed ID: 20815904
[TBL] [Abstract][Full Text] [Related]
11. Atypical PKCiota contributes to poor prognosis through loss of apical-basal polarity and cyclin E overexpression in ovarian cancer.
Eder AM; Sui X; Rosen DG; Nolden LK; Cheng KW; Lahad JP; Kango-Singh M; Lu KH; Warneke CL; Atkinson EN; Bedrosian I; Keyomarsi K; Kuo WL; Gray JW; Yin JC; Liu J; Halder G; Mills GB
Proc Natl Acad Sci U S A; 2005 Aug; 102(35):12519-24. PubMed ID: 16116079
[TBL] [Abstract][Full Text] [Related]
12. PKCι Is a Promising Prognosis Biomarker and Therapeutic Target for Pancreatic Cancer.
Abdelatty A; Fang D; Wei G; Wu F; Zhang C; Xu H; Yao C; Wang Y; Xia H
Pathobiology; 2022; 89(6):370-381. PubMed ID: 35785767
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of atypical protein kinase C‑ι effectively reduces the malignancy of prostate cancer cells by downregulating the NF-κB signaling cascade.
Apostolatos AH; Ratnayake WS; Win-Piazza H; Apostolatos CA; Smalley T; Kang L; Salup R; Hill R; Acevedo-Duncan M
Int J Oncol; 2018 Nov; 53(5):1836-1846. PubMed ID: 30226591
[TBL] [Abstract][Full Text] [Related]
14. SNPs-Panel Polymorphism Variations in
Merabet N; Ramoz N; Boulmaiz A; Bourefis A; Benabdelkrim M; Djeffal O; Moyse E; Tolle V; Berredjem H
Biomedicines; 2023 Dec; 11(12):. PubMed ID: 38137497
[TBL] [Abstract][Full Text] [Related]
15. Genetic variants of antioxidant and xenobiotic metabolizing enzymes and their association with prostate cancer: A meta-analysis and functional in silico analysis.
Álvarez-González B; Porras-Quesada P; Arenas-Rodríguez V; Tamayo-Gómez A; Vázquez-Alonso F; Martínez-González LJ; Hernández AF; Álvarez-Cubero MJ
Sci Total Environ; 2023 Nov; 898():165530. PubMed ID: 37453710
[TBL] [Abstract][Full Text] [Related]
16. Atypical protein kinase Ciota plays a critical role in human lung cancer cell growth and tumorigenicity.
Regala RP; Weems C; Jamieson L; Copland JA; Thompson EA; Fields AP
J Biol Chem; 2005 Sep; 280(35):31109-15. PubMed ID: 15994303
[TBL] [Abstract][Full Text] [Related]
17. Confirmation of genetic variants associated with lethal prostate cancer in a cohort of men from hereditary prostate cancer families.
Karyadi DM; Zhao S; He Q; McIntosh L; Wright JL; Ostrander EA; Feng Z; Stanford JL
Int J Cancer; 2015 May; 136(9):2166-71. PubMed ID: 25273821
[TBL] [Abstract][Full Text] [Related]
18. Gene variation impact on prostate cancer progression: Lymphocyte modulator, activation, and cell adhesion gene variant contribution.
Casadó-Llombart S; Ajami T; Consuegra-Fernández M; Carreras E; Aranda F; Armiger N; Alcaraz A; Mengual L; Lozano F
Prostate; 2022 Oct; 82(14):1331-1337. PubMed ID: 35767366
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase Cι is a new prognostic factor in gastric cancer.
Kashihara H; Shimada M; Kurita N; Iwata T; Sato H; Yoshikawa K; Miyatani T; Takasu C; Matsumoto N
Surg Today; 2015 Jun; 45(6):759-64. PubMed ID: 25108825
[TBL] [Abstract][Full Text] [Related]
20. PKCι regulates nuclear YAP1 localization and ovarian cancer tumorigenesis.
Wang Y; Justilien V; Brennan KI; Jamieson L; Murray NR; Fields AP
Oncogene; 2017 Jan; 36(4):534-545. PubMed ID: 27321186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
